Clinical Coagulation, Malmö
11 – 20 of 655
                - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
        Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
 - 
                        Mark
        Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Fibrinogen genotypes and their impact on recurrence of venous thromboembolism and family history : A prospective population-based study
    
    
- Contribution to journal › Article
 
 - 2024
 - 
                        Mark
        Haemophilia A - In pursuit of optimised outcomes via personalised treatment
    (2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
 
 - 
                        Mark
        Future needs for continuing innovation in hemophilia : improving outcomes for individuals of all severities, including women and those in resource-constrained regions
    
    
- Contribution to journal › Scientific review
 
 - 
                        Mark
        Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8) : a prospective, multicentre, open-label, randomised, phase 3a trial
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Sicklecellsjukdom - vanliga och farliga komplikationer
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Recombinant FVIII replacement products for haemophilia A : An updated valuation by indirect comparison measuring area under the curve
    
    
- Contribution to journal › Debate/Note/Editorial
 
 - 
                        Mark
        Tissue factor (F3) gene variants and thrombotic risk among middle-aged and older adults : A population-based cohort study
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B) : 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial
    
    
- Contribution to journal › Article
 
 
